Trademark Snap Shot Publication Stylesheet (Table presents the data on Publication Approval) |
|||
OVERVIEW |
|||
SERIAL NUMBER | 88821077 | FILING DATE | 03/04/2020 |
REG NUMBER | 0000000 | REG DATE | N/A |
REGISTER | PRINCIPAL | MARK TYPE | TRADEMARK |
INTL REG # | N/A | INTL REG DATE | N/A |
TM ATTORNEY | YARD, JOHN S |
L.O. ASSIGNED | 115 |
PUB INFORMATION |
|||
RUN DATE | 08/14/2020 | ||
PUB DATE | 09/15/2020 | ||
STATUS | 681-PUBLICATION/ISSUE REVIEW COMPLETE | ||
STATUS DATE | 08/13/2020 | ||
LITERAL MARK ELEMENT | AMAZE | ||
DATE ABANDONED | N/A | DATE CANCELLED | N/A |
SECTION 2F | NO | SECTION 2F IN PART | NO |
SECTION 8 | NO | SECTION 8 IN PART | NO |
SECTION 15 | NO | REPUB 12C | N/A |
RENEWAL FILED | NO | RENEWAL DATE | N/A |
DATE AMEND REG | N/A |
FILING BASIS |
|||||
FILED BASIS | CURRENT BASIS | AMENDED BASIS | |||
1 (a) | NO | 1 (a) | NO | 1 (a) | NO |
1 (b) | YES | 1 (b) | YES | 1 (b) | NO |
44D | NO | 44D | NO | 44D | NO |
44E | NO | 44E | NO | 44E | NO |
66A | NO | 66A | NO | ||
NO BASIS | NO | NO BASIS | NO |
MARK DATA |
|
STANDARD CHARACTER MARK | YES |
LITERAL MARK ELEMENT | AMAZE |
MARK DRAWING CODE | 4-STANDARD CHARACTER MARK |
COLOR DRAWING FLAG | NO |
CURRENT OWNER INFORMATION |
|
PARTY TYPE | 10-ORIGINAL APPLICANT |
NAME | LEO Pharma A/S |
ADDRESS | Industriparken 55 Ballerup, 2750 |
ENTITY | 99-PUBLIC LIMITED COMPANY |
CITIZENSHIP | Denmark |
GOODS AND SERVICES |
|
INTERNATIONAL CLASS | 005 |
DESCRIPTION TEXT | Pharmaceutical and medical preparations for treatment of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and for treatment of the skin |
INTERNATIONAL CLASS | 038 |
DESCRIPTION TEXT | Providing online forums for users for the sharing and transmission of information and messages about skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin |
INTERNATIONAL CLASS | 042 |
DESCRIPTION TEXT | Scientific and medical research in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; Pharmaceutical and scientific research and development services, scientific research and testing of pharmaceuticals, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; providing information and consulting services in the field of scientific and pharmaceutical research and development services and scientific research in relation to skin diseases and treatment of the skin; testing of pharmaceuticals in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin |
INTERNATIONAL CLASS | 044 |
DESCRIPTION TEXT | Medical services in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin; medical and pharmaceutical consultation services and health consultation services, all in the field of skin diseases, atopic dermatitis, eczema, autoimmune and inflammatory diseases and in relation to treatment of the skin |
GOODS AND SERVICES CLASSIFICATION |
|||||||
INTERNATIONAL CLASS | 005 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 038 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 042 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
INTERNATIONAL CLASS | 044 | FIRST USE DATE | NONE | FIRST USE IN COMMERCE DATE | NONE | CLASS STATUS | 6-ACTIVE |
MISCELLANEOUS INFORMATION/STATEMENTS |
|
CHANGE IN REGISTRATION | NO |
PROSECUTION HISTORY |
||||
DATE | ENT CD | ENT TYPE | DESCRIPTION | ENT NUM |
08/13/2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | 010 |
08/11/2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | 009 |
08/11/2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | 008 |
08/11/2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | 007 |
03/31/2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | 006 |
03/31/2020 | GNRT | F | NON-FINAL ACTION E-MAILED | 005 |
03/31/2020 | CNRT | R | NON-FINAL ACTION WRITTEN | 004 |
03/30/2020 | DOCK | D | ASSIGNED TO EXAMINER | 003 |
03/10/2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 002 |
03/07/2020 | NWAP | I | NEW APPLICATION ENTERED IN TRAM | 001 |
CURRENT CORRESPONDENCE INFORMATION |
|
ATTORNEY | B. Brett Heavner |
CORRESPONDENCE ADDRESS | B. Brett Heavner FINNEGAN, HENDERSON, FARABOW, GARRETT & 901 NEW YORK AVENUE N.W. WASHINGTON DC 20001 |
DOMESTIC REPRESENTATIVE | NONE |